DOVER, Del. – The Food and Drug Administration is investigating the death of two Delaware hospital patients who were given the blood thinner heparin.
Officials at Beebe Medical Center in Lewes said three patients suffered adverse reactions after being given the drug last week. Two of the patients, a 71-year-old man and a 64-year-old woman, died over the weekend.
An FDA spokeswoman said the agency is working with the hospital and Baxter Healthcare Corp., provider of the drug, to determine what happened.